Ceruti M - Search Results

1

Docetaxel in combination with epirubicin in metastatic breast cancer: pharmacokinetic interactions.

Ceruti M, Tagini V, Recalenda V, Arpicco S, Cattel L, Airoldi M, Bumma C. Ceruti M, et al. Farmaco. 1999 Nov-Dec;54(11-12):733-9. doi: 10.1016/s0014-827x(99)00092-0. Farmaco. 1999. PMID: 10668172 Clinical Trial.

2

Pharmacokinetic monitoring of mycophenolate mofetil in kidney transplanted patients.

Brusa P, Ceruti M, Casullo R, Dosio F, Squiccimarro G, Segoloni GP, Cattel L. Brusa P, et al. Among authors: ceruti m. Farmaco. 2000 Apr;55(4):270-5. doi: 10.1016/s0014-827x(00)00039-2. Farmaco. 2000. PMID: 10966158

3

Synthesis, characterization and transfection activity of new saturated and unsaturated cationic lipids.

Arpicco S, Canevari S, Ceruti M, Galmozzi E, Rocco F, Cattel L. Arpicco S, et al. Among authors: ceruti m. Farmaco. 2004 Nov;59(11):869-78. doi: 10.1016/j.farmac.2004.06.007. Farmaco. 2004. PMID: 15544791

4

22,23-Epoxy-2-aza-2,3-dihydrosqualene derivatives: potent new inhibitors of squalene 2,3-oxide-lanosterol cyclase.

Viola F, Ceruti M, Balliano G, Caputo O, Cattel L. Viola F, et al. Among authors: ceruti m. Farmaco. 1990 Sep;45(9):965-78. Farmaco. 1990. PMID: 2282128

5

Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing water-soluble prodrugs of paclitaxel.

Ceruti M, Crosasso P, Brusa P, Arpicco S, Dosio F, Cattel L. Ceruti M, et al. J Control Release. 2000 Jan 3;63(1-2):141-53. doi: 10.1016/s0168-3659(99)00198-4. J Control Release. 2000. PMID: 10640588

6

Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes.

Crosasso P, Ceruti M, Brusa P, Arpicco S, Dosio F, Cattel L. Crosasso P, et al. Among authors: ceruti m. J Control Release. 2000 Jan 3;63(1-2):19-30. doi: 10.1016/s0168-3659(99)00166-2. J Control Release. 2000. PMID: 10640577

7

From conventional to stealth liposomes: a new frontier in cancer chemotherapy.

Cattel L, Ceruti M, Dosio F. Cattel L, et al. Among authors: ceruti m. Tumori. 2003 May-Jun;89(3):237-49. doi: 10.1177/030089160308900302. Tumori. 2003. PMID: 12908776 Review.

8

Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs.

Immordino ML, Brusa P, Rocco F, Arpicco S, Ceruti M, Cattel L. Immordino ML, et al. Among authors: ceruti m. J Control Release. 2004 Dec 10;100(3):331-46. doi: 10.1016/j.jconrel.2004.09.001. J Control Release. 2004. PMID: 15567500

9

2,3,4,5-tetrahydroxy-5-(4-hydroxyphenyl)valeric acid: a new cleavable monofunctional reagent for monoclonal antibody labeling.

Grosa G, Dosio F, Brusa P, Ceruti M, Delprino L, Cattel L. Grosa G, et al. Among authors: ceruti m. Farmaco. 1994 May;49(5):349-55. Farmaco. 1994. PMID: 8080618

10

A new 'solid phase' procedure to synthesize immunotoxins (antibody-ribosome inactivating protein conjugates).

Dosio F, Brusa P, Delprino L, Ceruti M, Grosa G, Cattel L, Bolognesi A, Barbieri L. Dosio F, et al. Among authors: ceruti m. Farmaco. 1993 Jan;48(1):105-15. Farmaco. 1993. PMID: 8457275

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Search Page

Filters